Literature DB >> 15632695

Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis.

Takahiro Nakazawa1, Hirotaka Ohara, Hitoshi Sano, Tomoaki Ando, Shigeru Aoki, Shinya Kobayashi, Tetsu Okamoto, Tomoyuki Nomura, Takashi Joh, Makoto Itoh.   

Abstract

OBJECTIVES: Sclerosing cholangitis (SC) with autoimmune pancreatitis (AIP) is similar to primary sclerosing cholangitis (PSC) with regard to cholangiographic findings, but only the former responds well to steroid therapy. This report concentrates on the clinical differences between these diseases.
METHODS: The presenting complaint or abnormality, associated disease, cholangiographic findings, pancreatic changes, treatment, and clinical course were studied for several cases of PSC (n = 27) and SC with AIP (n = 20).
RESULTS: SC with AIP as a diagnosis occurs abruptly with obstructive jaundice compared with PSC where diagnosis is often based on findings of asymptomatic liver test abnormalities. In addition, inflammatory bowel disease is only associated with PSC. The most prominent features of cholangiograms for the SC with AIP cases were stenosis of the lower common bile duct. However, sclerosing changes in the intra- and extrahepatic bile ducts or hilar hepatic region were observed for half of the cases. Only PSC showed stage III or IV liver biopsy findings. IgG4 was significantly higher in SC with AIP.
CONCLUSIONS: SC with AIP and PSC are different clinical entities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632695

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  58 in total

1.  Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT, endoscopic retrograde cholangiography and MR cholangiography.

Authors:  Jin Hee Kim; Jae Ho Byun; So Jung Lee; Seong Ho Park; Hyoung Jung Kim; Seung Soo Lee; Myung-Hwan Kim; Jihun Kim; Moon-Gyu Lee
Journal:  Eur Radiol       Date:  2012-06-03       Impact factor: 5.315

Review 2.  Autoimmune pancreatitis and IgG4-related systemic diseases.

Authors:  Lizhi Zhang; Thomas C Smyrk
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

Review 3.  [Autoimmune pancreatitis--a surgical disease?].

Authors:  J Kleeff; T Welsch; I Esposito; M Löhr; R Singer; M W Büchler; H Friess
Journal:  Chirurg       Date:  2006-02       Impact factor: 0.955

4.  IgG4-related sclerosing cholangitis: liver biopsy findings.

Authors:  Han Suk Ryu; Haeryoung Kim
Journal:  Korean J Hepatol       Date:  2011-03

Review 5.  Acute recurrent pancreatitis: an autoimmune disease?

Authors:  Raffaele Pezzilli
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 6.  Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Toshiro Fukui
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

Review 7.  Etiopathogenesis of primary sclerosing cholangitis.

Authors:  Roger Chapman; Sue Cullen
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

8.  Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Itaru Naitoh; Takahiro Nakazawa; Hirotaka Ohara; Tomoaki Ando; Kazuki Hayashi; Hajime Tanaka; Fumihiro Okumura; Satoru Takahashi; Takashi Joh
Journal:  J Gastroenterol       Date:  2009-07-28       Impact factor: 7.527

Review 9.  Diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Simizu; Takashi Joh
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

10.  Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.

Authors:  Masanori Koyabu; Kazushige Uchida; Hideaki Miyoshi; Yutaku Sakaguchi; Toshiro Fukui; Hiroki Ikeda; Makoto Takaoka; Junko Hirohara; Akiyoshi Nishio; Yoshiko Uemura; Shinji Uemoto; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2010-01-20       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.